Should you buy SBI, ITC, Divis, Paytm, Bank of Baroda, IndiGo shares now?
Most brokerages are bullish on large ap stocks such as ITC, SBI, Divis Lab as well as on stocks from broader markets like BoB, IndiGo, Paytm among others.
ITC, SBI and Divi's Laboratories each won a thumbs up from brokerages with their healthy set of results for the quarter ended December 2022. They are also positive on Paytm, Bank of Baroda and IndiGo among companies their reported their earnings last week.
Here's what brokerages make of some of the top stocks in focus on February 6:
ITC shares
Brokerages are upbeat on cigarettes-to-hotels conglomerate ITC after the company's strong earnings. Morgan Stanley and JPMorgan have maintained an ‘overweight’ rating on the stock.
ITC's strong results and positive implications from the Union Budget augur well for the stock, according to Morgan Stanley.
Brokerage | Rating | Target price |
CLSA | Outperform | Rs 415 |
Morgan Stanley | Overweight | Rs 415 |
JPMorgan | Overweight | Rs 425 |
Jefferies | Buy | Rs 450 |
Citi | Buy | Rs 425 |
Nomura | Buy | Rs 445 |
SBI shares
State Bank of India (SBI), the country's largest lender by assets, reported a strong set of results on Friday that was better than the estimates of most brokerages.
Brokerage | Rating | Target price |
CLSA | Buy | Rs 725 |
Morgan Stanley | Overweight | Rs 715 |
JP Morgan | Overweight | Rs 720 |
Goldman Sachs | Buy | Rs 788 |
Citi | Buy | Rs 700 |
Macquarie | Outperform | Rs 695 |
Jeffieries | Buy | Rs 760 |
Divis Labs shares
Brokerage | Rating | Target price |
Morgan Stanley | Underweight | Rs 2,766 |
Goldman Sachs | Buy | Rs 3,375 |
Jeffieries | Underperform | Rs 2,550 |
Bank of Baroda shares
Brokerage | Rating | Target price |
CLSA | Outperform | Rs 210 |
JP Morgan | Overweight | Rs 220 |
Morgan Stanley | Overweight | Rs 220 |
Citi | Buy | Rs 188 |
HSBC | Buy | Rs 228 |
Interglobe Aviation (IndiGo) shares
Brokerage | Rating | Target price |
UBS | Buy | Rs 2,550 |
JP Morgan | Overweight | Rs 2,400 |
Goldman Sachs | Buy | Rs 2,360 |
Citi | Sell | Rs 1,950 |
Paytm shares
Brokerages are upbeat on Paytm after the release of the digital payments company's financial results. CLSA, Goldman Sachs and CITI each have a ‘buy’ call on the stock.
Brokerage | Rating | Target price |
CLSA | Buy | Rs 750 |
Morgan Stanley | Equalweight | Rs 695 |
Goldman Sachs | Buy | Rs 1,150 |
Citi | Sell | Rs 1,061 |
Marico shares
Brokerages | Rating | Price Target |
CLSA | Reduce | Rs 530 |
JPMorgan | Overweight | Rs 585 |
Morgan Stanley | Overweight | Rs 582 |
Jefferies | Hold | Rs 550 |
Nomura | Neutral | Rs 565 |
M&M Financial Services shares
Brokerage | Rating | Target price |
CLSA | Buy | Rs 310 |
JPMorgan | Neutral | Rs 230 |
Jeffieries | Hold | Rs 225 |
CITI | Buy | Rs 285 |
Catch latest stock market updates here. For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.